Advertisement

Nepal Lube Oil Limited (NLO)

Manufacturing · Rs. 277.40 8.00 (+2.97%) as of Aug 18, 2026

Price — last 6 months

Full chart →
Open
277.40
High / Low
277.40 / 277.40
Prev. close
269.40
Volume
62
52-week high
52-week low
Market cap
24.29 Cr
Shares outstanding
8.76 L

MASTER score

Mechanical 0–100 technical ranking. Methodology →

Promoter holding79.76%
Public holding20.24%

Stock performance

1-week change
+2.97%
1-month change
+2.97%
3-month change
+2.97%
6-month change
+2.97%
YTD change
+9.17%
1-year change
+13.53%
1-month high
277.40
1-month low
277.40
From 52-week high
From 52-week low
180-day avg price
273.40
360-day avg price
262.29
Avg volume (1w)
62
Avg volume (1m)
62
Avg volume (6m)
32
Avg volume (12m)
27
Daily volatility (1m)
Beta vs NEPSE (1y)

Valuation

EPS (annualized)
EPS (TTM)
P/E
P/B
Book value / share
ROE
ROA
Net profit margin
2.02%
Graham number
Dividend yield
0.38%
Dividend 2081/2082
21.05% (1.05% cash + 20.00% bonus)

P/E and P/B use the latest close over per-share values from the company's most recent filed statement. Full dividend history →

Key indicators vs Manufacturing

EPS (Rs.)
N/A
min -6.29avg 452.86max 1,712.27
P/E
N/A
min 21.38avg 33.31max 47.11
P/B
N/A
min 2.01avg 4.98max 9.01
Networth / Share (Rs.)
N/A
min 98.04avg 1,518.08max 5,537.13
ROE (%)
N/A
min 0.00avg 10.89max 30.92

Technical indicators

RSI (14)95.69Overbought
MACD22.19Bullish
EMA 5266.11Bullish
EMA 20237.50Bullish
EMA 180
SMA 50198.13Bullish
SMA 200
Pivot levels (classic)
S3
277.40
S2
277.40
S1
277.40
PP
277.40
R1
277.40
R2
277.40
R3
277.40

Key financials — last 8 quarters

amounts in Rs · per-share in Rs

No filed statements found.

More Manufacturing stocks

NLO — frequently asked questions

What is Nepal Lube Oil Limited's share price?

Rs. 277.40 as of Aug 18, 2026, the latest NEPSE trading session (+2.97% on the day).

What dividend did NLO pay?

21.05% for fiscal year 2081/2082 (1.05% cash and 20.00% bonus shares).

Prices from the latest NEPSE session; fundamentals from the company's published quarterly statements. Research reference only — not investment advice.